EXECUTIVE SUMMARY
University of Florida researchers reveal popular joint supplements containing glucosamine may accelerate Alzheimer's disease progression in seniors.
Many older adults turn to glucosamine to manage aging joints, but for individuals with mild cognitive impairment, the supplement could be linked to faster progression to Alzheimer’s disease.
To investigate how glucosamine affects dementia risk and mortality, University of Florida researchers analyzed medical records of patients with mild cognitive impairment, tracked laboratory mouse models and examined healthy versus Alzheimer’s-affected human brains.